Salih Emri

5.2k total citations · 1 hit paper
58 papers, 3.4k citations indexed

About

Salih Emri is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Salih Emri has authored 58 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 6 papers in Surgery. Recurrent topics in Salih Emri's work include Occupational and environmental lung diseases (36 papers), Pleural and Pulmonary Diseases (17 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers). Salih Emri is often cited by papers focused on Occupational and environmental lung diseases (36 papers), Pleural and Pulmonary Diseases (17 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers). Salih Emri collaborates with scholars based in Türkiye, United States and Belgium. Salih Emri's co-authors include U. Gatzemeier, James T. Symanowski, E. Kaukel, James J. Rusthoven, Claude Denham, Clet Niyikiza, Paolo Paoletti, Christian Manegold, Pierre Ruffiè and Nicholas J. Vogelzang and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Salih Emri

53 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

2003 2.3k citations Nicholas J. Vogelzang, James J. Rusthoven et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Salih Emri Türkiye	18	2.9k	574	344	268	239	58	3.4k
Philippe Astoul France	30	3.0k 1.0×	388 0.7×	279 0.8×	211 0.8×	196 0.8×	177	3.5k
L. Tammilehto Finland	28	1.5k 0.5×	384 0.7×	102 0.3×	292 1.1×	299 1.3×	58	2.2k
Richard Attanoos United Kingdom	29	2.0k 0.7×	436 0.8×	146 0.4×	169 0.6×	176 0.7×	78	2.6k
Kelly J. Butnor United States	29	1.4k 0.5×	300 0.5×	153 0.4×	339 1.3×	199 0.8×	84	2.3k
Muzaffer Metintaş Türkiye	30	1.8k 0.6×	207 0.4×	272 0.8×	196 0.7×	179 0.7×	131	2.4k
James T. Symanowski United States	28	3.1k 1.1×	1.4k 2.4×	484 1.4×	680 2.5×	211 0.9×	172	4.8k
J. Bignon France	34	2.7k 0.9×	273 0.5×	226 0.7×	430 1.6×	590 2.5×	137	3.8k
Haining Yang United States	37	3.4k 1.2×	962 1.7×	213 0.6×	1.5k 5.6×	228 1.0×	76	5.4k
Thomas A. Sporn United States	27	2.0k 0.7×	463 0.8×	232 0.7×	337 1.3×	269 1.1×	88	2.7k
Claudio Bianchi Italy	20	1.2k 0.4×	167 0.3×	197 0.6×	129 0.5×	261 1.1×	122	1.9k

Countries citing papers authored by Salih Emri

Since Specialization

Citations

This map shows the geographic impact of Salih Emri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salih Emri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salih Emri more than expected).

Fields of papers citing papers by Salih Emri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salih Emri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salih Emri. The network helps show where Salih Emri may publish in the future.

Co-authorship network of co-authors of Salih Emri

This figure shows the co-authorship network connecting the top 25 collaborators of Salih Emri. A scholar is included among the top collaborators of Salih Emri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salih Emri. Salih Emri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vogelzang, Nicholas J., James J. Rusthoven, James T. Symanowski, et al.. (2023). Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma. Journal of Clinical Oncology. 41(12). 2125–2133. 18 indexed citations

Severcan, Mete, et al.. (2022). Rapid diagnosis of malignant pleural mesothelioma and its discrimination from lung cancer and benign exudative effusions using blood serum. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(10). 166473–166473. 18 indexed citations

Karabulut, Erdem, et al.. (2020). Effects of Genetic Polymorphisms of Drug Transporter ABCB1 (MDR1) and Cytochrome P450 Enzymes CYP2A6, CYP2B6 on Nicotine Addiction and Smoking Cessation. Frontiers in Genetics. 11. 571997–571997. 6 indexed citations

Emri, Salih, Saadettin Kılıçkap, Cem Kadılar, et al.. (2012). Serum Levels of Alpha-Tocopherol, Vitamin C, Beta-Carotene, and Retinol in Malignant Pleural Mesothelioma. Asian Pacific Journal of Cancer Prevention. 13(7). 3025–3029. 8 indexed citations

Carbone, Michele, Salih Emri, A. Umran Doğan, et al.. (2007). A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes. Nature reviews. Cancer. 7(2). 147–154. 174 indexed citations

Emri, Salih, et al.. (2006). Tumor suppressor gene alterations in patients with malignant mesothelioma due to environmental asbestos exposure in Turkey.. Journal of Carcinogenesis. 5(1). 23–23. 5 indexed citations

Demirkazık, Figen, et al.. (2005). Incidental localized (solitary) mediastinal malignant mesothelioma. British Journal of Radiology. 78(933). 858–861. 12 indexed citations

Emri, Salih, et al.. (2002). Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicology Letters. 127(1-3). 251–257. 62 indexed citations

Bozkurt, Murat Fani, et al.. (2001). Ventilation–Perfusion Lung Scan and Helical Computed Tomographic Findings in a Patient with Behçet’s Disease. Clinical Nuclear Medicine. 26(8). 721–722. 1 indexed citations

10.

Emri, Salih, Hakan Akbulut, Faruk Zorlu, et al.. (2001). Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma. Lung Cancer. 33(2-3). 109–114. 16 indexed citations

11.

Atimtay, Aysel T., Salih Emri, Ayşe Tülay Bağcı Bösi, & Ahmet Uğur Demır. (2000). Urban CO Exposure and Its Health Effects on Traffic Policemen in Ankara. Environmental Research. 82(3). 222–230. 28 indexed citations

12.

Çağlar, Meltem, Eser Lay Ergün, & Salih Emri. (2000). 99Tcm-MAA lung scintigraphy in patients with Behçetʼs disease: Its value and correlation with clinical course and other diagnostic modalities. Nuclear Medicine Communications. 21(2). 171–179. 13 indexed citations

13.

Dumortier, Pascal, et al.. (1998). Assessment of Environmental Asbestos Exposure in Turkey by Bronchoalveolar Lavage. American Journal of Respiratory and Critical Care Medicine. 158(6). 1815–1824. 39 indexed citations

14.

Özdemir, Oktay, et al.. (1996). FIBRINOLYTIC SYSTEM IN PLASMA AND PLEURAL FLUID IN MALIGNANT PLEURAL MESOTHELIOMA. Thrombosis Research. 84(2). 121–128. 11 indexed citations

15.

Vuyst, Paul De, Pascal Dumortier, Danielle Jacobovitz, et al.. (1994). Environmental Asbestosis Complicated by Lung Cancer. CHEST Journal. 105(5). 1593–1595. 8 indexed citations

16.

Şahin, Afsun, Lütfi Çöplü, Ziya Toros Selçuk, et al.. (1993). Malignant pleural mesothelioma caused by environmental exposure to asbestos or erionite in rural Turkey: CT findings in 84 patients.. American Journal of Roentgenology. 161(3). 533–537. 40 indexed citations

17.

Selçuk, Ziya Toros, et al.. (1992). Malignant Pleural Mesothelioma Due to Environmental Mineral Fiber Exposure in Turkey. CHEST Journal. 102(3). 790–796. 77 indexed citations

18.

Emri, Salih, et al.. (1991). Hypertrophic pulmonary osteoarthropathy in a patient with pulmonary alveolar microlithiasis. Thorax. 46(2). 145–146. 17 indexed citations

19.

Sıvrı, Bülent, et al.. (1989). The Expanding Spectrum of a Disease. The Nephron journals/Nephron journals. 52(2). 154–157. 14 indexed citations

20.

Kalyoncu, Alı Fuat, et al.. (1988). Yağ Embolisi ve Yağ Embolisi Sendromu. Turkiye Klinikleri Tip Bilimleri Dergisi. 8(6). 399–401. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact